“Colorectal Cancer Survivors” Program in Istanbul, Turkey and Its Impact on Cancer Awareness

Abstract

Background: Colorectal cancer (CRC) is fourth most frequent cancer in men and third most common cancer in women in Turkey according to GLOBOCAN 2012 data. Its age-standardized incidence is 16.6 per 100,000 population in both sexes. CRC screening is globally accepted program and was shown that reduces CRC mortality. Aim: Public awareness is highly important to increase screening rate and to decrease mortality from CRC. Methods: We initiated a social program for patients with CRC, which is called “Colorectal Cancer Survivors”. Program contained interactive talks with patients and their relatives during cocktail and lunch in selected five stars hotels. We performed this activity in 2011 and 2012 in Istanbul. We invited patients with CRC who already diagnosed and successfully treated in Istanbul University Institute of Oncology. They were all 5 years or more survivors after surgery alone for stage I and II disease or last chemotherapy cycle for stage III or some stage IV cases. During meetings, surgeons, medical and radiation oncologists shared latest information about the risk factors, prevention and treatment modalities with participants. Media health correspondents were also participated to these activities. We monitored and compared screening rate before and after 2011. As a source, we used the nation-based data of cancer screening of Ministry of Health. Results: In April 30th, 2011, and in March 29th, 2012, 34 survivors joined to this program. We offered “Certificate of 5-Year Survivor” and “Blue Bead” to all patients. Blue Bead is a kind of symbol of hope in Turkey. In 2014, we observed significant increase in CRC screening compared with 2011 in Istanbul and all over the country. Conclusion: Since 2011 until present, there is a significant increase in CRC screening in Turkey. Among many positive factors, some social programs using media such as our “CRC Survivors” program that gives the message that CRC is a treatable and also curable in early stages, may stimulate screening.